Skip to main content
Journal cover image

Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF.

Publication ,  Journal Article
Segar, MW; Keshvani, N; Singh, S; Patel, L; Parsa, S; Betts, T; Reeves, GR; Mentz, RJ; Forman, DE; Razavi, M; Saeed, M; Kitzman, DW; Pandey, A
Published in: JACC Heart Fail
April 2024

BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy is recommended to reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF). Frailty is common among patients with HFrEF and is associated with increased mortality risk. Whether the therapeutic efficacy of ICD is consistent among frail and nonfrail patients with HFrEF remains unclear. OBJECTIVES: The aim of this study was to evaluate the effect modification of baseline frailty burden on ICD efficacy for primary prevention among participants of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). METHODS: Participants in SCD-HeFT with HFrEF randomized to ICD vs placebo were included. Baseline frailty was estimated using the Rockwood Frailty Index (FI), and participants were stratified into high (FI > median) vs low (FI ≤ median) frailty burden groups. Multivariable Cox models with multiplicative interaction terms (frailty × treatment arm) were constructed to evaluate whether baseline frailty status modified the treatment effect of ICD for all-cause mortality. RESULTS: The study included 1,676 participants (mean age: 59 ± 12 years, 23% women) with a median FI of 0.30 (IQR: 0.23-0.37) in the low frailty group and 0.54 (IQR: 0.47-0.60) in the high frailty group. In adjusted Cox models, baseline frailty status significantly modified the treatment effect of ICD therapy (Pinteraction = 0.047). In separate stratified analysis by frailty status, ICD therapy was associated with a lower risk of all-cause mortality among participants with low frailty burden (HR: 0.56; 95% CI: 0.40-0.78) but not among those with high frailty burden (HR: 0.86; 95% CI: 0.68-1.09). CONCLUSIONS: Baseline frailty modified the efficacy of ICD therapy with a significant mortality benefit observed among participants with HFrEF and a low frailty burden but not among those with a high frailty burden.

Duke Scholars

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

April 2024

Volume

12

Issue

4

Start / End Page

757 / 767

Location

United States

Related Subject Headings

  • Stroke Volume
  • Risk Factors
  • Primary Prevention
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Frailty
  • Female
  • Defibrillators, Implantable
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Segar, M. W., Keshvani, N., Singh, S., Patel, L., Parsa, S., Betts, T., … Pandey, A. (2024). Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF. JACC Heart Fail, 12(4), 757–767. https://doi.org/10.1016/j.jchf.2023.06.009
Segar, Matthew W., Neil Keshvani, Sumitabh Singh, Lajjaben Patel, Shyon Parsa, Traci Betts, Gordon R. Reeves, et al. “Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF.JACC Heart Fail 12, no. 4 (April 2024): 757–67. https://doi.org/10.1016/j.jchf.2023.06.009.
Segar MW, Keshvani N, Singh S, Patel L, Parsa S, Betts T, et al. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF. JACC Heart Fail. 2024 Apr;12(4):757–67.
Segar, Matthew W., et al. “Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF.JACC Heart Fail, vol. 12, no. 4, Apr. 2024, pp. 757–67. Pubmed, doi:10.1016/j.jchf.2023.06.009.
Segar MW, Keshvani N, Singh S, Patel L, Parsa S, Betts T, Reeves GR, Mentz RJ, Forman DE, Razavi M, Saeed M, Kitzman DW, Pandey A. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF. JACC Heart Fail. 2024 Apr;12(4):757–767.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

April 2024

Volume

12

Issue

4

Start / End Page

757 / 767

Location

United States

Related Subject Headings

  • Stroke Volume
  • Risk Factors
  • Primary Prevention
  • Middle Aged
  • Male
  • Humans
  • Heart Failure
  • Frailty
  • Female
  • Defibrillators, Implantable